Ultrasound-guided salvage brachytherapy with interstitial hyperthermia shows low toxicity in locally recurrent prostate cancer
New prostate cancer treatment shows low side effects after 5 years
This prospective phase 2 trial evaluated ultrasound-guided salvage brachytherapy with interstitial hyperthermia in 109 patients with locally…
A new treatment for recurrent prostate cancer kept 93% of patients alive at 5 years with very low serious side effects.
Feasibility study fails to meet recruitment target for HDR brachytherapy vs SBRT in recurrent prostate cancer
Why is it so hard to recruit men for a second prostate cancer radiation study?
A 3-center randomized feasibility study of 23 patients with locally recurrent prostate cancer found planned recruitment targets were not met…
Men refused to let chance decide their second prostate cancer radiation treatment, causing a major study to fall far short of its recruitmen…